​

Vera Therapeutics Ownership | Who Owns Vera Therapeutics?

OverviewForecastFinancialsChart

Vera Therapeutics Ownership Summary

Vera Therapeutics is owned by 66.84% institutional investors, 1.21% insiders, and 31.96% retail investors. Avoro capital advisors is the largest institutional shareholder, holding 9.74% of VERA shares. State Street® SPDR® S&P® Biotech ETF is the top mutual fund, with 2.97% of its assets in Vera Therapeutics shares.

VERA Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockVera Therapeutics66.84%1.21%31.96%
SectorHealthcare Stocks 232.86%10.65%-143.51%
IndustryBiotech Stocks 382.13%10.41%-292.54%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Avoro capital advisors6.21M9.74%$180.46M
Blackrock funding, inc. /de4.83M7.56%$244.36M
Blackrock3.34M6.55%$120.76M
Kynam capital management, lp4.03M6.31%$117.05M
Price t rowe associates inc /md/3.67M5.75%$106.55M
Deerfield management company, l.p. (series c)3.64M5.71%$105.81M
Vanguard group3.57M5.59%$180.81M
Fmr2.84M4.46%$82.62M
Eversept partners, lp2.81M4.40%$81.60M
Sofinnova investments2.79M4.38%$81.19M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Kynam capital management, lp4.03M8.71%$117.05M
Tri locum partners lp1.19M7.95%$34.59M
Eversept partners, lp2.81M5.62%$81.60M
Portman32.80K4.48%$1.19M
Sofinnova investments2.79M4.44%$81.19M
Integral health asset management1.70M3.34%$49.40M
Exome asset management156.07K2.75%$4.54M
Bioimpact capital563.08K2.68%$16.36M
Avoro capital advisors6.21M2.33%$180.46M
Rhenman & partners asset management ab420.00K1.99%$21.27M

Top Buyers

HolderShares% AssetsChange
Point72 asset management1.27M0.06%1.27M
Tri locum partners lp1.19M7.95%777.09K
Kynam capital management, lp4.03M8.71%600.91K
Blackrock funding, inc. /de4.83M0.00%578.33K
Integral health asset management1.70M3.34%550.00K

Top Sellers

HolderShares% AssetsChange
Vestal point capital, lp760.00K1.00%-2.34M
Holocene advisors, lp---2.20M
Woodline partners lp737.58K0.10%-1.87M
T. rowe price investment management---1.68M
Paradigm biocapital advisors lp---1.44M

New Positions

HolderShares% AssetsChangeValue
Point72 asset management1.27M0.06%1.27M$36.97M
Pfm health sciences, lp513.68K1.15%513.68K$14.93M
Braidwell lp472.74K0.41%472.74K$13.74M
Vanguard fiduciary trust441.51K0.00%441.51K$17.76M
Hsbc297.02K0.00%297.02K$8.63M

Sold Out

HolderChange
Coldstream capital management-6.00
Geowealth management-6.00
Nelson, van denburg & campbell wealth management group-7.00
Capital performance advisors llp-11.00
Fortitude family office-14.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 2025146-19.34%42,673,172-34.42%660.64%91-9.90%42-12.50%
Sep 30, 2025175-0.57%63,626,8635.34%991.11%96-6.80%46-2.13%
Jun 30, 20251840.55%63,880,1552.67%1001.05%1089.09%47-4.08%
Mar 31, 20251861.64%62,983,0820.11%980.75%101-20.47%5035.14%
Dec 31, 2024174-2.25%59,594,28011.34%1081.14%12126.04%35-30.00%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
State Street® SPDR® S&P® Biotech ETF2.13M2.97%-21.07K
Vanguard Total Stock Mkt Idx Inv1.90M2.65%12.85K
Fidelity Growth Compy Commingled Pl O1.16M2.11%-
Vanguard US Total Market Shares ETF1.33M2.09%-2.90K
iShares Russell 2000 ETF1.45M2.02%12.22K
T. Rowe Price Health Sciences1.32M1.83%-123.81K
Fidelity Growth Compy Commingled Pl S1.20M1.68%1.47K
T. Rowe Price New Horizons1.12M1.57%-10.03K
US Small-Cap Growth II Equity Comp1.12M1.57%-11.19K
SPDR® S&P Biotech ETF878.00K1.38%1.96K

Recent Insider Transactions

DateNameRoleActivityValue
Apr 14, 2026Fordyce Marshall PRESIDENT AND CEOSell$40.96K
Apr 14, 2026Fordyce Marshall PRESIDENT AND CEOSell$353.11K
Apr 14, 2026Fordyce Marshall PRESIDENT AND CEOSell$616.99K
Feb 23, 2026Brenner Robert Chief Medical OfficerSell$90.31K
Feb 23, 2026Young Joseph R SVP, FINANCE, CHIEF ACCT OFFCRSell$130.86K

Insider Transactions Trends

DateBuySell
2026 Q2-3
2026 Q1-7
2025 Q415
2025 Q24-
2025 Q1-6

VERA Ownership FAQ

Who Owns Vera Therapeutics?

Vera Therapeutics shareholders are primarily institutional investors at 66.84%, followed by 1.21% insiders and 31.95% retail investors. The average institutional ownership in Vera Therapeutics's industry, Biotech Stocks , is 382.13%, which Vera Therapeutics falls below.

Who owns the most shares of Vera Therapeutics?

Vera Therapeutics’s largest shareholders are Avoro capital advisors (6.21M shares, 9.74%), Blackrock funding, inc. /de (4.83M shares, 7.56%), and Blackrock (3.34M shares, 6.55%). Together, they hold 23.84% of Vera Therapeutics’s total shares outstanding.

Does Blackrock own Vera Therapeutics?

Yes, BlackRock owns 6.55% of Vera Therapeutics, totaling 3.34M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 120.76M$. In the last quarter, BlackRock increased its holdings by 18.71K shares, a 0.56% change.

Who is Vera Therapeutics’s biggest shareholder by percentage of total assets invested?

Kynam capital management, lp is Vera Therapeutics’s biggest shareholder by percentage of total assets invested, with 8.71% of its assets in 4.03M Vera Therapeutics shares, valued at 117.05M$.

Who is the top mutual fund holder of Vera Therapeutics shares?

State Street® SPDR® S&P® Biotech ETF is the top mutual fund holder of Vera Therapeutics shares, with 2.97% of its total shares outstanding invested in 2.13M Vera Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools